<DOC>
	<DOCNO>NCT00847288</DOCNO>
	<brief_summary>Medtronic , Inc. sponsor OptiVol® Care Pathway Study , prospective , randomize , multi-center , post-market clinical trial United States . The purpose clinical trial compare monthly versus quarterly review Cardiac Compass® Trends OptiVol initiation clinical action . It hypothesize monthly review Cardiac Compass Trends OptiVol shorten time clinical action compare quarterly review .</brief_summary>
	<brief_title>OptiVol® Care Pathway</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Subject ( subject 's legally authorize representative ) willing able sign date write consent form Authorization Access Use Health Information Subject least 18 year age Subject willing able comply Clinical Investigation Plan Subject willing able transmit data use Medtronic CareLink® Network Subject market release right atrial ( RA ) ( applicable ) , right ventricular ( RV ) , leave ventricular ( LV ) ( applicable ) lead one follow generator implant : Concerto® CRTD Model C154DWK , Virtuoso® DR ICD Model D154AWG , Virtuoso® VR ICD Model D154VWC , Consulta™ CRTD Model D224TRK , Secura™ DR ICD Model D224DRG , Secura™ VR ICD Model D224VRC , future market release Medtronic generator wireless telemetry , Cardiac Compass OptiVol Fluid Status Monitoring , support Medtronic CareLink Network Subject enrol concurrent study exception study approve Medtronic Clinical Trial Leader prior enrollment Subject life expectancy le 1 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Implantable Cardioverter Defibrillator ( ICD )</keyword>
	<keyword>Cardiac Resynchronization Therapy Defibrillator ( CRT D )</keyword>
	<keyword>OptiVol®</keyword>
</DOC>